483 Takeda Pharmaceutical Company Sep 2010

483 Takeda Pharmaceutical Company Sep 2010

Dell Moller FDA, Parul Patel FDA$119.00 - Available Now

FDA investigators audited the Takeda Pharmaceutical Company - Osaka, Japan facility and issued inspectional observations (via FDA 483) on 14 Sep 2010.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Sep 2010
  • Location: Osaka, Japan
  • FEI: 3002808311
Add To Cart